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Abstract
Background: Extracorporeal carbon dioxide removal (ECCO2R) is a promising yet
limited researched therapy for hypercapnic respiratory failure in acute respiratory
distress syndrome and exacerbated chronic obstructive pulmonary disease. Herein,
we describe a new mock circuit that enables experimental ECCO2R research without
animal models. In a second step, we use this model to investigate three experimental
scenarios of ECCO2R: (I) the influence of hemoglobin concentration on CO2 removal. (II)
a potentially portable ECCO2R that uses air instead of oxygen, (III) a low-flow ECCO2R
that achieves effective CO2 clearance by recirculation and acidification of the limited
blood volume of a small dual lumen cannula (such as a dialysis catheter).
Results: With the presented ECCO2R mock, CO2 removal rates comparable to previous
studies were obtained. The mock works with either fresh porcine blood or diluted
expired human packed red blood cells. However, fresh porcine blood was preferred
because of better handling and availability. In the second step of this work, hemoglobin
concentration was identified as an important factor for CO2 removal. In the second
scenario, an air-driven ECCO2R setup showed only a slightly lower CO2 wash-out than the
same setup with pure oxygen as sweep gas. In the last scenario, the low-flow ECCO2R,
the blood flow at the test membrane lung was successfully raised with a recirculation
channel without the need to increase cannula flow. Low recirculation ratios resulted in
increased efficiency, while high recirculation ratios caused slightly reduced CO2 removal
rates. Acidification of the CO2 depleted blood in the recirculation channel caused an
increase in CO2 removal rate.
Conclusions: We demonstrate a simple and cost effective, yet powerful, “in-vitro”
ECCO2R model that can be used as an alternative to animal experiments for many
research scenarios. Moreover, in our approach parameters such as hemoglobin level can
be modified more easily than in animal models.
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Background
Extracorporeal carbon dioxide elimination (ECCO2R) is a method to counteract hyper-
capnic respiratory failure, e.g., in severe acute respiratory distress syndrome (ARDS).
Furthermore, ECCO2R may be used in the management of patients with acute exacer-
bations of chronic obstructive pulmonary disease (COPD) or patients waiting for lung
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transplant [1, 2]. As mechanical ventilation in ARDS therapy can lead to ventilator-
induced lung injury, ECCO2R can be used to enable ultra-protective ventilation in pa-
tients without life-threatening hypoxemia [3–6].
Today, effective ECCO2R therapy requires blood flow rates of more than 1 L/min and con-
sequently cannulation with relatively large cannulas [1, 3]. Moreover, pure oxygen is fre-
quently used as sweep gas in ECCO2R therapy, in order to create a diffusion gradient for
CO2 to be cleared from the blood [4]. The invasiveness of catheters to generate a sufficient
blood flow (BF), as well as mobility limitations due to heavy oxygen bottles, are burdens for
potential mobile ECCO2R devices [5]. Another limitation of current ECCO2R devices is the
exclusive permeability of the membrane lung (ML) for gaseous substances and hence the im-
permeability for dissolved bicarbonate [6]. Since the majority of carbon dioxide is transported
as chemically bound HCO3
−, only approximately 10% of the total CO2 can pass the ML, ne-
cessitating high extracorporeal blood flows to sufficiently deplete the blood of CO2 [6].
So far, experimental evaluation of ECCO2R setups heavily relies on animal models
that are costly and require animal facilities. Considerable efforts to avoid animal experi-
ments are made by both the scientific community and politics. As an alternative, MLs
can be tested in mock circuits. Different mock designs have been described in the
literature [7–10]. The aim of our study is to present a new mock circuit that reflects
the anatomy of a mammal body connected to an ECCO2R more closely and to validate
that mock in three experimental scenarios.
Methods
Composition of the dual-loop circuit
Standard experiment protocol
The presented in vitro ECCO2R mock consisted of two circuits. The primary circuit
was responsible for creating a hypoxic and hypercapnic (venous) environment, which
represented the simulated vena cava, while the test ECCO2R circuit washed out CO2
and oxygenated the venous blood from the primary circuit.
The primary circuit consisted of a Getinge PLS (Maquet Cardiopulmonar GmbH,
Getinge Group, Rastatt, Germany) circuit composed of a Rotaflow pump, Quadrox
membrane lung, and BIOLine® coated PVC tubings. Two luer-lock connectors were in-
stalled into the circuit at 10 cm and 30 cm up-stream the centrifugal pump (Fig. 1).
Sweep gas of the Quadrox PLS was provided via a gas blender with separate regulation
of N2, CO2, and O2 flows. Out of several flow rate combinations a sweep gas flow
(V̇ Sweep ) of 7.5 L/min N2 and 0.55 L/min CO2 was chosen to create a venous car-
bon dioxide partial pressure (pvCO2) between 45 mmHg ± 5mmHg and a venous
oxygen saturation of 65% ± 5% (data not shown). Blood flow in the primary circuit
was set to 5 L/min. For temperature control of 37 °C, a Maquet HU 35 (Maquet)
was used accordingly.
Via the two luer-lock connectors, the test ECCO2R circuit was connected to the main cir-
cuit. This junction between primary and test circuit could be throttled and simulated the
cannulas in this model. The blood flow through these luer-lock connectors was called “can-
nula flow” in this work. The test circuit used 1/4 PVC tubings, a second Rotaflow centrifugal
pump, and a pediatric Getinge Quadrox iD ML as the test ML. A V̇ Sweep was applied to the
pediatric Quadrox iD ML. At the sweep gas outlet of the ML, a mass flow sensor
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(TSI41403) and a side-stream capnometer (Philips Intellivue) were installed. Blood flow in
the test circuit could be adjusted by closing one of the luer-lock connectors partly or adjust-
ing the rotations per minute on the Rotaflow pump.
As default, V̇ Sweep rates of 0.3, 0.5, 0.7, 1, 2, 4, 6, and 7 L/min and blood flows of 0.6
L/min were used in the test circuit. One set of MLs was used per experiment. Each ex-
periment was run for a maximum time of 2 h with one blood filling. A shift of up to
two base excess points in 2 h was tolerated.
CO2 removal rates (N = 6) were calculated from the sweep gas flow rate V̇ Sweep at the
sweep outlet, the carbon dioxide partial pressure pgCO2, and the atmospheric pressure
pges according to the following formula:
V̇CO2 ¼ V̇ Sweep
pgCO2
pges
Fig. 1 Schematic layout of the mock. The mock consists of two interconnected circuits with one
membrane lung (ML) each. The primary circuit represents the simulated organism. It has a blood flow of 5
L/min and creates a hypoxic and hypercapnic (venous) environment with N2 and CO2 as sweep gases. The
actual ECCO2R setup to be evaluated is built into the test circuit. CO2 removal over the ML in the test setup
is quantified. In this work, the influence of different hemoglobin concentrations (12, 7, and 4 g/dL), different
sweep gases (O2 vs. air), and low-flow scenarios (blood flow amplification with recirculation channel,
acidification of recirculated blood) on CO2 removal are simulated
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Choice of test fluid
The mock was filled with either 600 mL of fresh porcine blood or expired human
packed red blood cells (PRBC). Porcine blood was added with 10,000 IE Heparin to
avoid clotting, 1 g Meropenem to avoid bacterial growth during the measurement, and
diluted with a solution of 0.9% saline to a hemoglobin concentration (Hb) of 7 g/dL. As
an alternative, PRBC could also be used as test fluid after they were diluted with
phosphate-buffered saline (1x) to a Hb of 7 g/dL and adjusted to a pH of 7.20 ± 0.30
with 1000 mmol/L NaHCO3 solution. However, in this work, the default test fluid was
undiluted porcine blood.
In order to evaluate the two blood fluids, CO2 removal rates of fresh porcine blood
and human expired PRBC were compared. Blood gas analyses were performed for both
circuit fluids and compared. For fresh porcine blood, pH was in range of 7.20 ± 0.30,
bicarbonate in the range from 20 to 25mmol/L, and venous saturation of oxygen 65%
± 5%. In the shown PRBC measurement, the pH was 7.30 bicarbonate 21 mmol/L and
venous saturation of oxygen 69%. Lactate was used to assess quality of the blood fluid.
For fresh porcine blood, lactate values of up to 10mmol/L before the measurement
were tolerated. For expired PRBC, lactate levels of up to 20mmol/L the beginning of
the measurement series had to be tolerated.
Evaluation of three experimental ECCO2R scenarios
Hemoglobin concentration and CO2 removal
Three different hemoglobin levels (12, 7, 4 g/dL) were obtained by diluting fresh por-
cine blood with a solution of 0.9% saline and 24mmol/L NaHCO3. V̇ Sweep and blood
flow were set according to standard protocol. Blood gas analyses confirmed that bicar-
bonate was kept constantly at 24 mmol/L ± 3mmol/L.
The air-driven ECCO2R
Comparison of pure oxygen and air as sweep gases Pure oxygen or compressed air
from gas cylinders were used to create the sweep gas flow. V̇ Sweep and BF were set ac-
cording to standard protocol.
The low-flow ECCO2R
Addition of a recirculation channel to the setup A recirculation channel with vari-
able throttle was introduced to the test ECCO2R circuit according to Fig. 1. A part of
the blood behind the test ML was brought back to the pump of the test circuit. There-
fore, blood flow through the test ML was higher than the blood flow at the junction be-
tween test circuit and primary circuit (i.e., the simulated cannula flow). In this setup,
V̇ Sweep was kept constant at 5 L/min pure oxygen. The effect on CO2 removal of a recir-
culation channel was compared to the regular circuit by closing the loop fully.
Acid-enhanced recirculation The acid-enhanced recirculation channel was built simi-
lar to the recirculation channel described before. An infusion of 0.9% NaCl adjusted to
a pH of 1.0 with 25% hydrochloric acid was added via luer-lock to the recirculation
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channel (Fig. 1). Two different setups were compared. (A) A simulated cannula flow of
260 mL/min, a recirculation flow of 180 mL/min, and an acid infusion rate of 500 mL/h
were chosen to evaluate the CO2 removal rate of the test ML. (B) The second simula-
tion used a simulated cannula flow of 290 mL/min and a recirculation flow of 170 mL/
min and an infusion rate of 1200ml/h. V̇ Sweep was kept constantly at 5 L/min for both
setups.
Statistics
Statistical analysis was performed with GraphPad Prism 5.02 (GraphPad Software, Inc.,
La Jolla, CA). Parametric data was presented as mean ± SD. The Kolmogorov-Smirnov
test was used to test for Gaussian distribution. Differences between groups were tested
with unpaired t test and ANOVA for Gaussian-distributed groups and with the Mann
Whitney U test and Kruskal-Wallis test for non-Gaussian-distributed groups. P values
< 0.05 (*) and < 0.01 (**) were considered significant, and p values < 0.001 (***) were
considered highly significant.
Results
Composition of the dual-loop circuit
Using the presented mock circuit model, continuous steady state measurements, with
adjustable pvCO2 and O2 saturation values, were possible.
Choice of test fluid
The measurements with expired packed red blood cells showed CO2 removal rates
comparable to the results with fresh porcine blood diluted to the same hemoglobin
concentration (Fig. 2). The non-linear progression of PRBC and porcine blood was
similar.
Fig. 2 Choice of test fluid. CO2 removal rates (V̇CO2 ) were similar for fresh porcine blood and diluted packed
red blood cells. This measurement was done with a blood flow of 0.6 L/min and O2 sweep gas flows (
V̇Sweep) of 0.3, 0.5, 0.7, 1, 2, 4, 6, and 7 L/min in the test circuit
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Evaluation of three experimental ECCO2R scenarios
Hemoglobin concentration and CO2 removal
A strong association of CO2 removal rate and hemoglobin concentration was found.
The CO2 removal of the test ML was higher when a high Hb was used (Fig. 3). The dif-
ferences in CO2 removal between the three Hb values were highly significant (p <
0.001). The higher the sweep gas flow rate, the greater was the difference of the three
Hb values in CO2 removal.
The air-driven ECCO2R
Comparison of pure oxygen and air as sweep gases Performance of CO2 removal (
V̇CO2 ) showed a plateau at V̇ Sweep ≥ 6 L/min and above. Below that plateau, CO2 re-
moval rate increased with rising V̇ Sweep rates, although the measured pgCO2 at the sweep
gas outlet of the ML was decreasing with rising sweep gas flow rates (Table 1).
The CO2 removal using air was, in most cases, 15–20% less efficient (p < 0.05) com-
pared to pure oxygen at the same V̇ Sweep.
The low-flow ECCO2R
Impact of a recirculation channel on CO2 removal The opening of the channel for
recirculation caused an increase of the blood flow through the ML of the test circuit.
However, the dynamics in fluid flow between the primary and test circuits as a whole
was changed. The pump speed of the test circuit had to be increased to maintain a sim-
ulated cannula flow, similar to that before onset of recirculation.
The addition of a recirculation channel in some settings achieved an increased CO2 re-
moval rate while in other settings decreased CO2 removal rates are observed (Table 2).
The reduced CO2 removal rates were mainly observed for very high recirculation
Fig. 3 Hemoglobin concentration and CO2 removal. Hemoglobin concentrations were set to 12, 7, and 4 g/
dL. A blood flow of 0.6 L/min and O2 sweep gas flows (V̇Sweep) of 0.3, 0.5, 0.7, 1, 2, 4, 6, and 7 L/min were
used in the test circuit. CO2 removal rate was higher for high hemoglobin concentrations (p < 0.001)
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ratios ( recirculation ratio ¼ recirculation flowmembrane flow 100% ) relative to the simulated cannula
flow, such as 88%.
Impact of HCl infusion on CO2 removal The addition of an HCl infusion at 500 mL/
h (1200 mL/h) to the recirculation channel with a simulated cannula flow of 260 mL/
min (290 mL/min) and a recirculation flow of 180 mL/min (170 mL/min) led to a sig-
nificant increase in CO2 removal rate (Fig. 4). The effect was more pronounced for an
acid infusion rate of 1200 mL/h than for 500 mL/h.
Table 1 Impact of pure oxygen and air as sweep gases on CO2 removal
V̇Sweep [L/min] Sweep gas pgCO2 [kPa] V̇CO2 [mL/min] p
7 O2 1.41 98.92 ± 2.28 p < 0.05
7 Air 1.26 89.68 ± 4.06
6 O2 1.56 94.03 ± 0.97 p < 0.05
6 Air 1.35 81.37 ± 1.07
4 O2 2.12 85.05 ± 1.04 p < 0.05
4 Air 1.77 72.00 ± 1.16
2 O2 3.09 62.51 ± 0.98 p < 0.05
2 Air 2.74 54.67 ± 0.64
1 O2 4.05 40.91 ± 1.41 p < 0.05
1 Air 3.58 36.14 ± 0.57
0.7 O2 4.35 30.14 ± 0.62 ns
0.7 Air 4.27 29.61 ± 0.55
0.5 O2 4.58 23.29 ± 0.32 p < 0.05
0.5 Air 4.12 20.11 ± 0.4
0.3 O2 4.7 13.99 ± 0.25 p < 0.05
0.3 Air 4.3 13.13 ± 0.11










910 Closed 910 66.67 ± 0.69 p < 0.05
900 500 1400 35.7 69.63 ± 0.73
500 Closed 500 58.31 ± 0.61 ns
500 280 780 35.9 57.97 ± 0.4
300 Closed 300 48.66 ± 0.46 p < 0.05
300 240 540 44.4 49.93 ± 0.43
200 Closed 200 42.25 ± 0.71 ns
200 140 340 41.2 42.32 ± 0.99
100 Closed 100 28.76 ± 1.22 p < 0.05
100 80 180 44.4 30.93 ± 0.62
330 Closed 330 55.38 ± 0.88 ns
330 1140 1470 77.6 54.45 ± 1.26
180 Closed 180 45.16 ± 0.96 p < 0.05
180 1310 1490 87.9 41.24 ± 0.43
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Discussion
Composition of the dual-loop circuit
The ECCO2R mock described in this work shows a reasonable alternative method to
gain information about ECCO2R and simulate clinical settings. While animal-based
ECMO or ECCO2R test setups remain gold standard, for certain scientific issues, the
animal model might not add additional benefit despite being a lot more complex and
costlier. The test circuit in this model was inspired by the Homburg lung, the most
commonly used ECCO2R platform in our center, which is based on the Rotaflow plat-
form and a pediatric Quadrox iD oxygenator [11]. One advantage of our mock setup in
comparison to animal-based ECCO2R experiments is the ability to modify blood gas
parameters and the hemoglobin level more easily.
Other mock circulation models have been described in the literature that differ how-
ever from our approach. Schumer et al. created a closed loop ECMO mock with a sin-
gle pump, a deoxygenation ML, and the tested oxygenation ML in series [10].
Barret et al. demonstrated a low blood flow single loop ECCO2R model and
used a Hemolung test ML. The impact of the sweep gas flow (air) on CO2 re-
moval and the relationship between V̇ Sweep and dead space was investigated [7].
Moreover, Sun et al. tested four commercial MLs in a closed loop circuit with
one centrifugal pump [12]. The CO2 removal rates for the tested Maquet Quadrox
pediatric iD MLs were in the same range as our results using the same ML for a
Hb of 15 g/dL (Table 3).
In contrast to those approaches, our model consists of two interconnected circuits
where each circuit has its own centrifugal pump. This allows to create individual blood
flows in the primary circuit and the test circuit. Consequently, the physiological blood
flow of a mammal body (primary circuit, BF = 5 L/min) connected to an ECCO2R
Table 3 Comparison of CO2 removal rates of the pediatric oxygenator Quadrox iD for different
blood flow (BF) and sweep gas flows (V̇Sweep)
V̇Sweep This study (BF 0.6 L/min) Sun et al. (BF 0.5 L/min) [12]
1 L/min 41mL/min 39mL/min
2 L/min 63mL/min 61mL/min
4 L/min 85mL/min 92mL/min
Fig. 4 Acidification of recirculated blood. Acidification of blood in the recirculation channel leads to a
significantly increased CO2 removal. a V̇Sweep of 5 L/min, simulated cannula flow of 260 mL/min,
recirculation flow of 180 mL/min, and HCl infusion rate of 500 mL/h. b V̇Sweep of 5 L/min, simulated cannula
flow of 290 mL/min, recirculation flow of 170 mL/min, and HCl infusion rate of 1200 mL/h
Schwärzel et al. Intensive Care Medicine Experimental            (2020) 8:52 Page 8 of 13
device (test circuit) can be demonstrated more precisely. Similar to our approach, de
Villiers Hugo et al. have created a dual mock to investigate a low-flow system with a
modified dialysis unit [8].
Unlike most of the described mocks, our construction allows to measure continu-
ously [1, 10, 13]. Using N2 and CO2 as sweep gases on the primary circuit, a constant
venous milieu with a pvCO2 of 45 ± 5mmHg can be established throughout the whole
measurement series.
Limitations of the dual-loop model
However, our study has some limitations. As most experiments were carried out with
porcine rather than human blood, the data cannot be directly compared to clinical pa-
tients. However, we did evaluate diluted expired human packed red blood cells, al-
though in one exemplary scenario, and found no relevant difference in CO2 elimination
compared to fresh porcine blood. However, like in most mock circuits, the absence of
endothelium and its interaction with the blood limits generalization.
Moreover, the two preclinical scenarios, air-driven and low-flow ECCO2R, were mea-
sured with undiluted porcine blood samples, as obtained by the butcher, in order to
keep already complex setups as simple as possible. Porcine Hb values of 13.5 ± 1.5 g/dL
are rather high compared to typical clinical scenarios of patients with hypercapnic re-
spiratory failure. However, a scenario with diluted porcine blood samples was added to
consider the association of different hemoglobin concentrations and CO2 removal. Not
for clinical reasons but to analyze a broad range, the lowest Hb level was set to a rather
low 4 g/dL.
Choice of test fluid
We conducted this experiment to demonstrate that both fresh porcine blood and di-
luted expired packed red blood cells qualify for mock circuit fluid with rather similar
properties. While we used both fluids in our initial tests with mock circuits, at this
point, we prefer fresh porcine blood. Availability of diluted packed red blood cells is
limited, as clinical operations only rarely generate expired PRBC. Those few PRBC that
are older than 6 weeks have to be discarded and can be redirected to research.
Although expiration of PRBC does happen, timing is not predictable, and quality and
storage time of those expired packed red blood cells is very inhomogeneous. Moreover,
we observed that deoxygenating the system to a sufficient venous environment in the
primary circuit was easier when using fresh pig blood. The impact of storage time on
biochemical processes of PRBC has been described in literature before.
Prolonged storage of PRBC leads to a left shift of the oxygen dissociation curve and
the affinity of oxygen for hemoglobin in the PRBC increases [14, 15]. Moreover, the in-
crease of affinity results in a decrease of 2,3-bisphosphoglycerate concentration in
PRBC during storage longer than 2 weeks [16]. Furthermore, a lower pH, due to lactate
production by erythrocytes, induces the depletion of 2,3-bisphosphoglycerate and in-
creases the affinity of hemoglobin for O2 [15]. As a result, the ability to deoxygenate in
the primary circuit is better for fresh porcine blood than for old PRCBs.
In addition, fresh porcine blood samples did not require pH adjustment, as there was
very little variance in the samples and the amount of lactate was much lower.
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Moreover, it was paramount to avoid relevant pH drifts during experiments, and fresh
porcine blood was also more stable in this regard.
Evaluation of three experimental ECCO2R scenarios
Hemoglobin concentration and CO2 removal
The hemoglobin level in the blood has a strong impact on the ability of the test ML to
remove CO2, as hemoglobin is one of the carriers of CO2 in the blood. About 13% of
the total CO2 amount in the blood is bounded on Hb to carbaminohemoglobin [16,
17]. A lower hemoglobin concentration in the blood reduces the ability to unload CO2
from carbaminohemoglobin in exchange for O2 at the test ML according to human
lungs [18, 19]. Moreover, as described by the Haldane effect, the upload of oxygen to
hemoglobin in the test ML induces a release of protons (H+) from the hemoglobin mol-
ecules [20, 21]. In the blood, there is a reversible equilibrium between bicarbonate and
carbon dioxide catalyzed by the enzyme carbonic anhydrase that is stored in erythro-
cytes [15, 20, 22]. Reducing hemoglobin level, the buffer capacity to provide protons
declines as well as the amount of the enzyme carbonic anhydrase to catalyze the reac-
tion. Therefore, less CO2 can possibly be eliminated at the test ML.
The air-driven ECCO2R
In this scenario, various sweep gas flows are tested to find an economical V̇ Sweep range.
While a decrease in oxygen flow by 1 or 2 L/min alone might not seem significant in
terms of macroeconomics, it is nevertheless an important step to a more efficient
ECCO2R design.
As shown in Table 2, for a blood flow of 600 mL/min, a plateau is reached, applying
V̇ Sweep rates ≥ 6 L/min. Therefore, an efficient mobile ECCO2R with limited sweep gas
supply should stay at the lower sweep gas flow rates of this plateau. Similar results have
been shown by Barret et al. for a blood flow of 400 mL/min and a plateau for V̇ Sweep ≥
4 L/min [7].
We propose that the plateau is caused by a decrease of the final pgCO2 in the gas
phase at the outflow of the test ML, when high V̇ Sweep rates are applied. We assume,
that using low sweep flow rates, an equilibrium between CO2 in gas and in the blood is
established early in the hollow fiber of the ML, and the pgCO2 determined is similar to
the pvCO2 in the blood. Increasing V̇ Sweep , the equilibrium is established subsequently,
or the period of contact is too short to reach equilibrium. Therefore, the measured
pgCO2 of high flow rates is lower than for low flow rates. According to Fick’s principle,
a high difference between pvCO2 and pgCO2 induces a higher diffusion flux, hence a
higher CO2 elimination. However, high sweep flow rates result in a final pgCO2 in the
gas phase that is practically zero. A further increase cannot decrease the pgCO2 in the
gas phase below zero and therefore has minimal effect on the diffusion gradient and
the CO2 removal rate.
The second aspect of this experiment was the idea to use ambient air as a sweep gas
alternative to pure oxygen. This would eliminate the above discussed problem of sweep
gas economy altogether. However, as shown in Table 2, CO2 removal rate of ambient
air is significantly lower than that of pure oxygen. We assume, that this stands in close
connection to the Haldane effect as well [21]. Ambient air leads to lower oxygen
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concentrations in the blood compared to pure oxygen. By uploading less oxygen to
hemoglobin, less CO2 dissociates from the molecule in exchange [17]. Moreover, a
lower pO2 in the blood causes a smaller release of protons from hemoglobin and there-
fore less CO2 formation and dissociation [18]. Despite this reduction on CO2 removal,
we still like the idea of a portable ECCO2R with ambient air. A turbine setup, such as
used by many CPAP devices, could utilize the infinite supply of ambient air and is most
likely less heavy than a gas cylinder. This makes a patient on such a hypothetic
ECCO2R device independent from pure oxygen and gas cylinders and might promote
the mobility of the patient.
The low-flow ECCO2R
A major problem of low-flow cannulas, such as dialysis catheters, is their inability to
create a sufficient BF across the ML, leading to an increased risk of ML clotting. A pre-
vious study has shown that there is a correlation of areas with low flow speed and
thrombus formation in membrane oxygenators [23]. One solution for this problem is
to increase flow speed in the membrane lungs by using smaller oxygenators, with
smaller cross sections. However, in our opinion it is preferable to use commonly avail-
able oxygenators with higher surface area. Therefore, another approach is the use of a
recirculation channel, a trick to recirculate the limited blood volume from the cannula
more than once before sending it back into the patient. However, only flow volume is
increased by such a recirculation channel, not the CO2 content, because the recircu-
lated blood was already CO2 depleted during the first passage through the ML. To fur-
ther increase CO2 removal from the mixed blood, HCO3
− can be converted into
membrane diffusible CO2 with the addition of acid.
Impact of a recirculation channel on CO2 elimination When first evaluating recircu-
lation channels, an obviously reduced CO2 removal compared to an otherwise identical
setup without a recirculation channel was noticeable. Pump rotation speed was kept
constant when opening the loop inducing a lower simulated cannula flow (data not
shown).
However, for the comparisons shown in this paper, we decided that the simulated
cannula flow, which defines the amount of CO2-rich blood that goes into the test setup,
should be held constant. With matched simulated cannula flows, the overall trend for
lower CO2 removal rates with recirculation channels is gone, albeit at the expense of
higher pump rotation speeds.
Small and large recirculation ratios vary CO2 removal efficiency because of a different
CO2 content in the mixed blood and a different total membrane flow. Increasing the
recirculation ratio decreases the carbon dioxide partial pressure in the mixed blood
(pmCO2) hence the transmembrane gradient, but on the other hand, increases flow
speed in the ML, two factors with inverse influence on CO2 removal rate. With ECMO
flow rates, rather than ECCO2R flow rates in this work, Madhani et al. also found an
increased CO2 transfer rate for blood recirculation [24]. However, in his setup, a can-
nula flow of 3.5 L/min and a recirculation flow of 6.5 L/min were used. This recircula-
tion ratio of 65% is above our efficiency increasing ratios but below those recirculation
ratios, where our setup showed a decrease in efficiency. We suggest that there is an
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optimal recirculation ratio, somewhere between 50 and 75%. The evaluation of this
optimum should be subject of future research.
Impact of acidification of the recirculated blood Achieving increased CO2 removal
by local acidification has been described in previous studies [2, 5, 6, 9, 25–27]. How-
ever, this is the first study to combine an acidification step with a recirculation channel.
The acidification can be used to overcompensate slight disadvantages in the CO2 washout
of recirculation channels with high recirculation ratio. The acid transforms bicarbonate
(effectively chemically dissolved CO2) into physically dissolved CO2, hence restoring the
pmCO2 level in the recirculated blood and increasing CO2 removal in the ML. In our
study, the strong inorganic acid HCl was used, as Cl− has little metabolic effects. However,
like previous studies, we also identified hemolysis caused by both the acid and mechanical
blood trauma in the bends of the recirculation channel as major problem that needs to be
solved before this approach can be used in clinical studies [25].
Conclusion
Our ECCO2R mock represents a novel method to generate data with animal free exper-
iments as it simulates a mammal body connected to an ECCO2R. As a practical conse-
quence of this work, we suggest that a gas cylinder free and mobile ECCO2R could use
air as sweep gas with only moderate reduction in efficiency. Moreover, we conclude
that recirculation channels and acid enhancement are promising tools to improve
ECCO2R therapy that should be topic of future research.
All in all, our model is an improvement of so far established mock circuits, and more
ECCO2R setups will be tested in the future.
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